Remestemcel-L is under clinical development by Mesoblast and currently in Phase III for Crohn's Disease (Regional Enteritis).

The chain filed for bankruptcy protection in September, saying inflation and high interest rates caused consumers to pull ...

From drug shortages to the approval of a nasal spray flu vaccine ... predictable out-of-pocket costs for improving medication ...

A new state law caps the price of specific medications and medical supplies for chronic diseases. The law, which could save ...

STAE COLLEGE, Pa. (WTAJ) — A noncitizen of the United States was arrested in State College after being accused of shoplifting ...